Intraarterial chemotherapy of malignant melanoma metastatic to the liver

Hepato-Gastroenterology

Volumn 48, Issue 42, 2001, Pages 1711-1715

  Melichar, B ^a   Dvorak J ^a   Jandik, P ^a   Touskova M ^a   Solichova D ^a   Megancova J ^a   Voboril, Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Immunotherapy; Liver metastases; Melanoma; Regional chemotherapy

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DACARBAZINE; MELPHALAN; NEOPTERIN; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; COMORBIDITY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOSTIMULATION; LIVER DISEASE; LIVER METASTASIS; LYMPHOCYTE COUNT; MALE; MELANOMA; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; PALATAL NEOPLASMS; SKIN NEOPLASMS; UVULA;

EID: 0035665582     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Prognostic factors in metastatic melanoma
2. Survival in metastatic ocular melanoma
3. Prognosis and treatment of disseminated uveal melanoma
4. Metastatic cancer to the liver
5. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
6. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
7. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy
8. Metastasectomy in malignant melanoma
9. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon-gamma: Results of a tumor necrosis factor dose-escalation study
10. Isolated hyperthermia chemotherapy perfusion for limb melanoma
11. Regionale intraarterielle chemotherapie mit dacarbazin bei isolierten lebermetastasen eines malignen melanoms
12. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
13. Complete remission of the liver metastases of anorectal malignant melanoma with regional chemotherapy: A case report
14. Treatment of uveal melanoma metastatic to the liver
15. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, inferferon alfa, and interleukin-2 for patients with metastatic melanoma
16. Hepatic artery infusion and chemoembolization in the management of liver metastases
17. Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infsuion with cisplatin and vinblastine
18. Intrahepatic interleukin-2 with chemotherapy for unresectable liver metastases: A randomized multicenter trial
19. Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: A prospective randomized study
20. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem
21. Metastatic melanoma: Transplenic immunostimulation - A new therapeutical alternative for an ever-challenging disease
22. Regional administration of lymphokine-activated killer cells can be superior to intravenous application
23. Adoptive immunotherapy of primary and metastatic liver cancer via hepatic artery catheter
24. Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies
25. Repeat hepatic resection for recurrent metastatic melanoma
26. Interleukin-2 dose, blood monocyte and CD25+lymphocyte counts as predictors of clinical response to interleukin-2 therapy in patients with renal cell carcinoma
27. Effects of subcutaneous recombinant IL-2 on humoral immunity in advanced cancer patients
28. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma
29. Altered tryptophan and neopterin metabolism in cancer patients treated wtih recombinant interleukin 2
30. Elevation de la neopterine apres traitement par le facteur stimulant des colonies granulo-macrophagiques (GM-CSF)
31. Urinary neopterin excretion in colorectal cancer